About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: January 2010
The i-Man Cometh
i-pod. i-phone. i-pad. i-think. therefore i am. This week, if you've been living under a rock, there is news for you. The i-pad was unveiled by Apple. The i-pad puts together a lot of qualities that many say will change … Continue reading
Posted in Uncategorized
Comments Off on The i-Man Cometh
Social Media and Medicine Paradox – Is There a Movement or Not?
I am in Europe, where I have been giving a talk on Social Media and Medicine, similar to one I gave last week in Canada. In fact, I've been giving talks on Social Media and Medicine all over. Certainly, it … Continue reading
Posted in Uncategorized
2 Comments
FDA Needs to Tell a Coherent Story on BPA – Bring Back the Talk Paper!
When the new leadership took over at FDA, they inherited one of many problems when it comes to the troubled history of the FDA's response to issues associated with the presence of bisphenol-A (BPA) in or near the foods we … Continue reading
Posted in Uncategorized
Comments Off on FDA Needs to Tell a Coherent Story on BPA – Bring Back the Talk Paper!
Changing Communications – Changing Public Policy and Healthcare Reform
I have been struck by how quickly the communications landscape is changing. When television was invented, it took decades before there was widespread uptake and "I Love Lucy" was playing in everyone's living room. In 1981, there were news stories … Continue reading
Posted in Uncategorized
1 Comment
Twongress – The Power of Twitter in Congress
I need to start off by stating the obvious – this is a bit of a departure from my FDA beat. However, I work in health care public affairs and have for many years. As any reader of this blog … Continue reading
Posted in Uncategorized
Comments Off on Twongress – The Power of Twitter in Congress